Sourcing Lirafugratinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Alovudine
pharmaceutical raw material
Sourcing Lirafugratinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Lirafugratinib is an orally bioavailable inhibitor of fibroblast growth factor receptor 2 (FGFR2), designed as a pharmaceutical raw material for research and manufacturing applications. It acts by binding to FGFR2 and inhibiting the downstream signal transduction pathways involved in cellular proliferation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Lirafugratinib (CAS 2549174-42-5) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[4-[4-amino-5-[3-fluoro-4-(4-methylpyrimidin-2-yl)oxyphenyl]-7-methylpyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-methylprop-2-enamide
XOQVZSSDIQQUGO-UHFFFAOYSA-N
CC1=NC(=NC=C1)OC2=C(C=C(C=C2)C3=C(N(C4=NC=NC(=C34)N)C)C5=CC=C(C=C5)NC(=O)C(=C)C)F